Literature DB >> 33362476

Revisiting PNS Plasticity: How Uninjured Sensory Afferents Promote Neuropathic Pain.

Emily L Tran1, LaTasha K Crawford1.   

Abstract

Despite the widespread study of how injured nerves contribute to chronic pain, there are still major gaps in our understanding of pain mechanisms. This is particularly true of pain resulting from nerve injury, or neuropathic pain, wherein tactile or thermal stimuli cause painful responses that are particularly difficult to treat with existing therapies. Curiously, this stimulus-driven pain relies upon intact, uninjured sensory neurons that transmit the signals that are ultimately sensed as painful. Studies that interrogate uninjured neurons in search of cell-specific mechanisms have shown that nerve injury alters intact, uninjured neurons resulting in an activity that drives stimulus-evoked pain. This review of neuropathic pain mechanisms summarizes cell-type-specific pathology of uninjured sensory neurons and the sensory ganglia that house their cell bodies. Uninjured neurons have demonstrated a wide range of molecular and neurophysiologic changes, many of which are distinct from those detected in injured neurons. These intriguing findings include expression of pain-associated molecules, neurophysiological changes that underlie increased excitability, and evidence that intercellular signaling within sensory ganglia alters uninjured neurons. In addition to well-supported findings, this review also discusses potential mechanisms that remain poorly understood in the context of nerve injury. This review highlights key questions that will advance our understanding of the plasticity of sensory neuron subpopulations and clarify the role of uninjured neurons in developing anti-pain therapies.
Copyright © 2020 Tran and Crawford.

Entities:  

Keywords:  dorsal root ganglia (DRG); mechanoreceptor; neuropathic pain; primary afferent; sensory ganglia; spared nerve injury (SNI); spinal nerve ligation (SNL); uninjured afferents

Year:  2020        PMID: 33362476      PMCID: PMC7759741          DOI: 10.3389/fncel.2020.612982

Source DB:  PubMed          Journal:  Front Cell Neurosci        ISSN: 1662-5102            Impact factor:   5.505


  105 in total

1.  Distribution of intravenously injected protein tracers in peripheral ganglia of adult mice.

Authors:  B Arvidson
Journal:  Exp Neurol       Date:  1979-02       Impact factor: 5.330

2.  Importance of hyperexcitability of DRG neurons in neuropathic pain.

Authors:  Jin Mo Chung; Kyungsoon Chung
Journal:  Pain Pract       Date:  2002-06       Impact factor: 3.183

3.  Topographical differences in the vascular permeability of the peripheral nervous system.

Authors:  Y Olsson
Journal:  Acta Neuropathol       Date:  1968-01-02       Impact factor: 17.088

4.  Hyperpolarization-activated cyclic nucleotide-gated channels contribute to spontaneous activity in L4 C-fiber nociceptors, but not Aβ-non-nociceptors, after axotomy of L5-spinal nerve in the rat in vivo.

Authors:  Laiche Djouhri; Trevor Smith; Ahmad Ahmeda; Mohammad Alotaibi; Xiechuan Weng
Journal:  Pain       Date:  2018-07       Impact factor: 6.961

5.  A Transcriptomic Analysis of Neuropathic Pain in Rat Dorsal Root Ganglia Following Peripheral Nerve Injury.

Authors:  Wuping Sun; Dongquan Kou; Zhijian Yu; Shaomin Yang; Changyu Jiang; Donglin Xiong; Lizu Xiao; Qiwen Deng; Hengtao Xie; Yue Hao
Journal:  Neuromolecular Med       Date:  2019-12-19       Impact factor: 3.843

6.  Increased neuropeptide Y (NPY)-like immunoreactivity in rat sensory neurons following peripheral axotomy.

Authors:  S Wakisaka; K C Kajander; G J Bennett
Journal:  Neurosci Lett       Date:  1991-04-01       Impact factor: 3.046

7.  The pattern of expression of the voltage-gated sodium channels Na(v)1.8 and Na(v)1.9 does not change in uninjured primary sensory neurons in experimental neuropathic pain models.

Authors:  Isabelle Decosterd; Ru-Rong Ji; Salahadin Abdi; Simon Tate; Clifford J Woolf
Journal:  Pain       Date:  2002-04       Impact factor: 6.961

8.  Differential regulation of immune responses and macrophage/neuron interactions in the dorsal root ganglion in young and adult rats following nerve injury.

Authors:  David Vega-Avelaira; Sandrine M Géranton; Maria Fitzgerald
Journal:  Mol Pain       Date:  2009-12-10       Impact factor: 3.395

9.  Gene Expression Profiling of Cutaneous Injured and Non-Injured Nociceptors in SNI Animal Model of Neuropathic Pain.

Authors:  Temugin Berta; Florence E Perrin; Marie Pertin; Raquel Tonello; Yen-Chin Liu; Alexander Chamessian; Ann C Kato; Ru-Rong Ji; Isabelle Decosterd
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

10.  Accumulation of Cav3.2 T-type Calcium Channels in the Uninjured Sural Nerve Contributes to Neuropathic Pain in Rats with Spared Nerve Injury.

Authors:  Wen Chen; Ye-Nan Chi; Xue-Jing Kang; Qing-Ying Liu; Hao-Lin Zhang; Zhi-Hua Li; Zi-Fang Zhao; Yin Yang; Li Su; Jie Cai; Fei-Fei Liao; Ming Yi; You Wan; Feng-Yu Liu
Journal:  Front Mol Neurosci       Date:  2018-02-08       Impact factor: 5.639

View more
  3 in total

1.  Neurodynamic Treatment Promotes Mechanical Pain Modulation in Sensory Neurons and Nerve Regeneration in Rats.

Authors:  Giacomo Carta; Benedetta Elena Fornasari; Federica Fregnan; Giulia Ronchi; Stefano De Zanet; Luisa Muratori; Giulia Nato; Marco Fogli; Giovanna Gambarotta; Stefano Geuna; Stefania Raimondo
Journal:  Biomedicines       Date:  2022-05-31

2.  scRNA-sequencing reveals subtype-specific transcriptomic perturbations in DRG neurons of PirtEGFPf mice in neuropathic pain condition.

Authors:  Chi Zhang; Ming-Wen Hu; Xue-Wei Wang; Xiang Cui; Jing Liu; Qian Huang; Xu Cao; Feng-Quan Zhou; Jiang Qian; Shao-Qiu He; Yun Guan
Journal:  Elife       Date:  2022-10-20       Impact factor: 8.713

3.  Targeted ubiquitination of sensory neuron calcium channels reduces the development of neuropathic pain.

Authors:  Linlin Sun; Chi-Kun Tong; Travis J Morgenstern; Hang Zhou; Guang Yang; Henry M Colecraft
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-13       Impact factor: 12.779

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.